Novel mechanisms of nonsteroidal anti-inflammatory drug-induced renal toxicity (Q36544954)

14 August 2017

1 reference

title

Novel mechanisms of nonsteroidal anti-inflammatory drug-induced renal toxicity (English)

1 reference

14 August 2017

0 references

Kathleen M Knights

1

1 reference

14 August 2017

Paraskevi Tsoutsikos

series ordinal

2

1 reference

14 August 2017

John O Miners

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Expert Opinion on Drug Metabolism & Toxicology

14 August 2017

published in

1 reference

14 August 2017

volume

1

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

399-408

1 reference

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Nonsteroidal anti-inflammatory drugs: effects on kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Mefenamic acid nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Reversible Renal Failure and Nephrotic Syndrome Associated with Nonsteroidal Anti-Inflammatory Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Arachidonic acid as a bioactive molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Glucuronidation of linoleic acid diols by human microsomal and recombinant UDP-glucuronosyltransferases: identification of UGT2B7 as the major isoform involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Urinary metabolites of leukotriene B4 in the human subject

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

P-450 metabolites of arachidonic acid in the control of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Intracellular unesterified arachidonic acid signals apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Analysis of the toxic effects of linoleic acid, 12,13-cis-epoxyoctadecenoic acid, and 12,13-dihydroxyoctadecenoic acid in rabbit renal cortical mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Cytotoxicity of linoleic acid diols to renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Renal effects of COX-2-selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Renal failure associated with the use of celecoxib and rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Nephrotoxic potential of selective cyclooxygenase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Drug glucuronidation by human renal UDP-glucuronosyltransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Renal toxicity of the nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Hepatic disposition of electrophilic acyl glucuronide conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Drug bioactivation, covalent binding to target proteins and toxicity relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

Dual acting anti-inflammatory drugs: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.3.399

21 January 2018

Identifiers

DOI

10.1517/17425255.1.3.399

1 reference

14 August 2017

1 reference